WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the indep…
Category: Business
MediPrint Ophthalmics Advances Glaucoma Program, Expands Patent Portfolio, and Prepares for Key Industry Presentation
SAN DIEGO–(BUSINESS WIRE)–MediPrint® Ophthalmics, a clinical-stage ophthalmic drug delivery company, continues to advance its innovative glaucoma program following the successful completion of its Phase 2b clinical trial for LL-BMT1. As the company p…
Warby Parker to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2024 will be releas…
Bausch + Lomb Provides Update on Potential Sale
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following update on a potential sale, which was disclosed in December 2…
iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems Inc. (“iVeena”), a biopharmaceutical company advancing IVMED-85 for the treatment of pediatric myopia, today announced that it has closed its fully subscribed Series B-2 financing of $3 million. …
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment…
Sapio Sciences Selected by LabConnect to Transform Laboratory Operations
BALTIMORE–(BUSINESS WIRE)–Sapio Sciences, the science-aware™ lab informatics platform, today announced that LabConnect, a global leader in central laboratory services, has chosen Sapio LIMS (Laboratory Information Management System) to digitally tran…
McKesson Advances Specialty Leadership; Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings, LLC
IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC (PRISM Vision), a premier provider of general ophthalmology and retin…
Aldeyra Therapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
Intraocular Lens Market Projected to Reach US$ 7.16 Billion by 2033 with Notable CAGR of 5.40%, Expansion Fueled by Aging Population and Technological Advancements – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lens Market Report by Product, Material, End User, Region and Company Analysis 2025-2033” report has been added to ResearchAndMarkets.com’s offering. The global Intraocular Lens (IOL) market is poised for subst…
VetnCare Announces Matthew J. Kirchner as Chief Executive Officer; Founder Dr. Andrew Moffatt to Continue Leadership Role as Chief Medical Officer
OAKLAND, Calif.–(BUSINESS WIRE)–VetnCare (or “the Company”), a growing community of veterinary hospitals based in Northern California, has appointed Matthew J. Kirchner as Chief Executive Officer. As part of the transition, Founder Dr. Andrew Moffatt…
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces the completion of the sale of its Avenova eyecare business and related assets to PRN Physician Recommended Nutriceuticals, L…
Des économies en vue : Specsavers réalise d’importantes économies sur trois ans en transférant sa fonction d’assistance d’Oracle à Spinnaker Support
DENVER–(BUSINESS WIRE)–Spinnaker Support (Spinnaker), à qui des entreprises du monde entier font confiance pour le support de leurs logiciels essentiels Oracle, SAP et VMware, a annoncé aujourd’hui qu’elle va permettre à Specsavers, spécialiste mondi…
Kostensenkung in Sicht: Specsavers profitiert von erheblichen Einsparungen durch die Umstellung von Oracle zu Spinnaker Support über drei Jahre
DENVER, Colorado, USA–(BUSINESS WIRE)–Spinnaker Support (Spinnaker) – ein Anbieter von Supportleistungen, dem Unternehmen weltweit bei der Unterstützung ihrer unverzichtbaren Oracle-, SAP- und VMware-Software vertrauen – wird dem globalen Augen- und …
Riassunto: Risparmi in vista: tre anni di grandi risparmi per Specsavers, spostando il passaggio della funzionalità di supporto da Oracle a Spinnaker Support
DENVER–(BUSINESS WIRE)–Spinnaker Support (Spinnaker), società di fiducia di aziende di tutto il mondo per supportare il software essenziale Oracle, SAP e VMware, oggi ha annunciato che consentirà lo Specsavers, lo specialista globale di ottica e cura…
GenSight Biologics Announces Publication of 5-Year Outcomes for Patients Treated Unilaterally with LUMEVOQ® Gene Therapy
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced severa…
Orthobond Delivers Its First OSTAGUARD™ Coated Implants for Surgery
PRINCETON, N.J.–(BUSINESS WIRE)–Orthobond Corporation, a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, today announced the successful in-house production and commercial delivery …
Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire monofocal and toric in…
Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine
JERSEY CITY, N.J.–(BUSINESS WIRE)–Character Biosciences, a pioneer in genetics-guided drug discovery and development, today announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative treatments for patien…